Decreased Renal K+ Excretion [PE]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Decreased Renal K+ Excretion [PE] includes 2 drugs with a combined 731 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
731
Combined Reports
All Decreased Renal K+ Excretion [PE] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| AMILORIDE | Amiloride Hydrochloride and Hydrochlorothiazide | 385 | 13 | 204 | 3.4% |
| TRIAMTERENE | Triamterene | 346 | 51 | 157 | 14.7% |
Common Side Effects in Decreased Renal K+ Excretion [PE] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 67 | 2 |
| Coma | 60 | 0 |
| Gastrooesophageal reflux disease | 60 | 0 |
| Pneumonia aspiration | 60 | 0 |
| Somnolence | 60 | 0 |
| Hyponatraemia | 51 | 5 |
| Diarrhoea | 42 | 5 |
| Hyperkalaemia | 42 | 0 |
| Underdose | 39 | 0 |
| Drug hypersensitivity | 37 | 0 |